Mechanisms of Mesenchymal Stem Cell‐Derived Exosomes in Dry Eye Disease: From Inflammation Pathways to Therapeutic Prospects
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Stem Cells International
- Vol. 2026 (1)
Abstract
Dry eye disease (DED) is a chronic ocular surface disorder triggered by tear film imbalance, in which inflammatory disruption of immune homeostasis constitutes the core pathological mechanism. Mesenchymal stem cell‐derived exosomes (MSC‐Exos) offer promising anti‐inflammatory therapeutic potential through immune modulation, tissue repair, and their inherently low immunogenicity. This review elucidates MSC‐Exos’ molecular regulation of DED inflammation, demonstrating their suppression of the TLR4/NF‐κB signaling axis, the IRAK1/TRAF6/NF‐κB cascade reaction, the STAT3 transcriptional regulatory network, and the NLRP3 inflammasome activation pathway, while revealing a synergistic mechanism through which MSC‐Exos ameliorate the ocular surface inflammatory microenvironment by modulating the Th17/Treg immune balance via the gut–eye axis and facilitating FBXW7‐mediated ubiquitination degradation pathways. Despite this therapeutic potential, clinical translation is hampered by exosomal heterogeneity, difficulties in standardization, and suboptimal delivery efficiency and long‐term efficacy. Future progress will require the integration of nanotechnology and gene editing to enhance therapeutic functionality, ultimately positioning MSC‐Exos as precision biologics for DED.Keywords
Funding Information
- Natural Science Foundation of Hunan Province (2025JJ81029)
- Natural Science Foundation of Hunan Province (2025JJ81006)
This publication has 103 references indexed in Scilit:
- The Effects of Mesenchymal Stem Cell-Derived Exosomes on the Attenuation of Dry Eye Disease in Sjögren Syndrome Animal ModelTissue Engineering and Regenerative Medicine, 2025
- Microneedle loaded with luteolin-colostrum-derived exosomes: a dropless approach for treatment of glaucomaDrug Delivery and Translational Research, 2025
- BMSC-derived exosomes regulate the Treg/Th17 balance through the miR-21-5p/TLR4/MyD88/NF-κB pathway to alleviate dry eye symptoms in miceIn Vitro Cellular & Developmental Biology - Animal, 2024
- B-Cell Receptor Repertoire: Recent Advances in Autoimmune DiseasesClinical Reviews in Allergy & Immunology, 2024
- Human mesenchymal stem cell secretomes: Factors affecting profiling and challenges in clinical applicationCell and tissue research, 2024
- Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunityImmunity, Inflammation and Disease, 2024
- KPNA2 Silencing, Regulated by E3 Ubiquitin Ligase FBXW7, Alleviates Endothelial Dysfunction and Inflammation Through Inhibiting the Nuclear Translocation of p65 and IRF3: A Possible Therapeutic Approach for AtherosclerosisInflammation, 2023
- Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United StatesJAMA Ophthalmology, 2022
- Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunityJournal of Leukocyte Biology, 2022
- The expression of miRNA‐146a‐5p and its mechanism of treating dry eye syndromeJournal of Clinical Laboratory Analysis, 2020